id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-006435-4o8uu6d5	Kivity, Shaye	Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature	2009-07-10		.txt	text/plain	14141	874	36	Although convincing evidence is lacking for the use of IVIg in view of the severity and the refractory nature of several cases of Evans' syndrome, IVIg may be considered among the treatment options generally together with CS with or without immunosuppressive therapy (strength of recommendation IIb). Level of evidence B Evidence comes only from one crossover randomized placebo-controlled trial which supports the use of IVIg in HIV-associated thrombocytopenia, especially when platelet count is very low or the risk of bleeding is high (strength of recommendation IIa). Level of evidence B IVIg is not used for the treatment of CMV infection but may be helpful in treatment of hemophagocytic syndrome related to CMV and other viruses (see hematology section); there is some evidence for its effectiveness in preventing seroconversion in transplant patients who are immunosuppressed (strength of recommendation IIa).	./cache/cord-006435-4o8uu6d5.txt	./txt/cord-006435-4o8uu6d5.txt